28 related articles for article (PubMed ID: 22348684)
1. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
[TBL] [Abstract][Full Text] [Related]
2. Prolactin induces the production of Th17 and Th1 cytokines/chemokines in murine Imiquimod-induced psoriasiform skin.
Hau CS; Kanda N; Tada Y; Shibata S; Sato S; Watanabe S
J Eur Acad Dermatol Venereol; 2014 Oct; 28(10):1370-9. PubMed ID: 24304413
[TBL] [Abstract][Full Text] [Related]
3. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
[TBL] [Abstract][Full Text] [Related]
4. Host-directed therapies for bacterial and viral infections.
Kaufmann SHE; Dorhoi A; Hotchkiss RS; Bartenschlager R
Nat Rev Drug Discov; 2018 Jan; 17(1):35-56. PubMed ID: 28935918
[TBL] [Abstract][Full Text] [Related]
5. Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463.
Imbertson LM; Beaurline JM; Couture AM; Gibson SJ; Smith RM; Miller RL; Reiter MJ; Wagner TL; Tomai MA
J Invest Dermatol; 1998 May; 110(5):734-9. PubMed ID: 9579537
[TBL] [Abstract][Full Text] [Related]
6. Effects of a novel topical immunomodulator, imiquimod, on keratinocyte cytokine gene expression.
Kono T; Kondo S; Pastore S; Shivji GM; Tomai MA; McKenzie RC; Sauder DN
Lymphokine Cytokine Res; 1994 Apr; 13(2):71-6. PubMed ID: 8061117
[TBL] [Abstract][Full Text] [Related]
7. Induction of cytokines in cynomolgus monkeys by the immune response modifiers, imiquimod, S-27609 and S-28463.
Wagner TL; Horton VL; Carlson GL; Myhre PE; Gibson SJ; Imbertson LM; Tomai MA
Cytokine; 1997 Nov; 9(11):837-45. PubMed ID: 9367544
[TBL] [Abstract][Full Text] [Related]
8. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells.
Suzuki H; Wang B; Shivji GM; Toto P; Amerio P; Tomai MA; Miller RL; Sauder DN
J Invest Dermatol; 2000 Jan; 114(1):135-41. PubMed ID: 10620129
[TBL] [Abstract][Full Text] [Related]
9. Effect of a novel topical immunomodulator, S-28463, on keratinocyte cytokine gene expression and production.
Fujisawa H; Shivji GM; Kondo S; Wang B; Tomai MA; Miller RL; Sauder DN
J Interferon Cytokine Res; 1996 Jul; 16(7):555-9. PubMed ID: 8836922
[TBL] [Abstract][Full Text] [Related]
10. Potential efficacy of imiquimod on immunity-related cytokines in murine skin in vivo and in human Langerhans cells in vitro.
Miao X; Luo D; Min W; Lin X; Wang D; Xu Y; Wu D
Int J Dermatol; 2012 Sep; 51(9):1116-22. PubMed ID: 22348684
[TBL] [Abstract][Full Text] [Related]
11. [New perspective in immunotherapy: local imiquimod treatment].
Kemény L; Nagy N
Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory and pharmacologic properties of imiquimod.
Sauder DN
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 2):S6-11. PubMed ID: 10861101
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
